European device companies will no longer be allowed to directly sponsor physician attendance at medical meetings, starting in 2018. In response, three prominent European interventional cardiologists warn that the change could have dire consequences, stifling education and potentially reducing attendance at European medical meetings by 30% to 50%.

http://www.medpagetoday.com/Cardiology/CardioBrief/55006?xid=nl_mpt_DHE_2015-12-05